Home > GAO Report: Update on Agency Efforts to Improve 340B Program Oversight
Posted July 18, 2017
GAO Report: Update on Agency Efforts to Improve 340B Program Oversight
The 340B Drug Pricing Program requires drug manufacturers to sell outpatient drugs at discounted prices to covered entities—eligible clinics, hospitals, and others—to have their drugs covered by Medicaid.